116 Publications (Page 4 of 5)
2006
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Wadehra, NavinFarag, Sherif SBolwell, BrianElder, PatrickPenza, Sam LKalaycio, MattAvalos, BelindaPohlman, BradMarcucci, GuidoSobecks, RonaldLin, ThomasAndrèsen, Steven and Copelan, Edward
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, (no. 12), pp. 1343-9, 2006/Dec. | Journal Article
 
OSU03012, a Novel Celecoxib Derivative, Induces Apoptosis in Multiple Myeloma Cells Independently of Caspase Activation
Zhang, ShuhongZhang, ShuhongWhite, Valerie LWhite, Valerie LJohnson, AmyJohnson, AmyChen, Ching-ShihChen, Ching-ShihFarag, Sherif S and Farag, Sherif S
Blood, vol. 108, (no. 11), pp. 5075, 2006-11-16. | Journal Article
 
OSU-HDAC42, a Novel Histone Deacetylase Inhibitor, Induces Apoptosis in a Caspase-Dependent Manner and Induces p21WAF1/CIP1 and p16 Expression in Multiple Myeloma Cell Lines
White, Valerie LWhite, Valerie LZhang, ShuhongZhang, ShuhongLucas, DavidLucas, DavidChen, Ching-ShihChen, Ching-ShihFarag, Sherif S and Farag, Sherif S
Blood, vol. 108, (no. 11), pp. 5078, 2006-11-16. | Journal Article
 
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Farag, Sherif SArcher, Kellie JMrózek, KrzysztofRuppert, Amy SCarroll, Andrew JVardiman, James WPettenati, Mark JBaer, Maria RQumsiyeh, Mazin BKoduru, Prasad RNing, YiMayer, Robert JStone, Richard MLarson, Richard ABloomfield, Clara DStone, Richard MBloomfield, Clara DArcher, Kellie JMrózek, KrzysztofRuppert, Amy SCarroll, Andrew JVardiman, James WPettenati, Mark JBaer, Maria RQumsiyeh, Mazin BKoduru, Prasad RNing, YiMayer, Robert JFarag, Sherif S and Larson, Richard A
Blood, vol. 108, (no. 1), pp. 63-73, 2006/Jul/1. | Journal Article
 
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag, Sherif SBacigalupo, AndreaEapen, MaryHurley, CarolynDupont, BoCaligiuri, Michael ABoudreau, ChristianNelson, GeneOudshoorn, Machteldvan Rood, JonVelardi, AndreaMaiers, MartinSetterholm, MichelleConfer, DennisPosch, Phillip EAnasetti, ClaudioKamani, NayneshMiller, Jeffrey SWeisdorf, Daniel and Davies, Stella M
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol. 12, (no. 8), pp. 876-84, 2006/Aug. | Journal Article
2005
DC therapy? Let the natural killer answer
Farag, Sherif S
Blood, vol. 106, (no. 6), pp. 1892, 2005-09-15. | Journal Article
 
Diffuse alveolar hemorrhage following gemtuzumab ozogamicin
Lin, Thomas SPenza, Sam LAvalos Copelan, BelindaLucarelli, Maria RFarag, Sherif SByrd, John C and Copelan, Edward A
Bone Marrow Transplantation, vol. 35, (no. 8), pp. 823-4, Apr 2005. | Journal Article
 
FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.
Lin, Thomas SFlinn, Ian WModali, RamaLehman, Teresa AWebb, JenniferWaymer, SharonMoran, Mollie ELucas, Margaret SFarag, Sherif S and Byrd, John C
Blood, vol. 105, (no. 1), pp. 289-91, 2005/Jan/1. | Journal Article
 
Flavopiridol, Fludarabine and Rituximab Is a Highly Active Regimen in Indolent B-Cell Lymphoproliferative Disorders Including Mantle Cell Lymphoma
Lin, Thomas SFischer, BethMoran, Mollie EBuckner, Maureen MShank, RoshiniKraut, Eric HPorcu, PierluigiFarag, Sherif SEisenbeis, Charles FColevas, DimitriosGrever, Michael R and Byrd, John C
Blood, vol. 106, (no. 11), pp. 944, 2005-11-16. | Journal Article
 
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia
Farag, Sherif SBolwell, B. JElder, P. JKalaycio, M.Lin, T.Pohlman, B.Penza, Sam LMarcucci, GuidoBlum, WilliamSobecks, Ronald MAvalos Copelan, BelindaByrd, John C and Copelan, Edward A
Bone Marrow Transplantation, vol. 35, (no. 7), pp. 653-61, Apr 2005. | Journal Article
 
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Farag, Sherif SRuppert, Amy SMrózek, KrzysztofMayer, Robert JStone, Richard MCarroll, Andrew JPowell, Bayard LMoore, Joseph OPettenati, Mark JKoduru, Prasad RStamberg, JudithBaer, Maria RBlock, AnnemarieVardiman, James WKolitz, Jonathan ESchiffer, Charles ALarson, Richard A and Bloomfield, Clara D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 23, (no. 3), pp. 482-93, 2005/Jan/20. | Journal Article
 
Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma
Kraut, Eric HKraut, Eric HYoung, DonnYoung, DonnFarag, SherifFarag, SherifJames, Arthur GJames, Arthur GSolove, Richard J and Solove, Richard J
Leukemia Research, vol. 29, (no. 10), pp. 1234, 2005. | Journal Article
2004
Chronic graft-versus-host disease: where do we go from here?
Farag, S
Bone Marrow Transplantation, vol. 33, (no. 6), pp. 569-77, Mar 2004. | Journal Article
 
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
Farag, Sherif S and Caligiuri, Michael A
Advances in pharmacology (San Diego, Calif.), vol. 51, pp. 295-318, 2004. | Journal Article
 
Depletion of alloreactive T cells: which cell?
Farag, Sherif S
Blood, vol. 104, (no. 12), pp. 3423, 2004-12-01. | Journal Article
 
Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia.
Farag, Sherif SFlinn, Ian WModali, RamaLehman, Teresa AYoung, Donn C and Byrd, John C
Blood, vol. 103, (no. 4), pp. 1472-4, 2004/Feb/15. | Journal Article
 
Immunotherapeutic strategies of stem cell transplant in lymphoma
Farag, Sherif S
Clinical advances in hematology & oncology : H&O, vol. 2, (no. 10), pp. 638, 2004-Oct. | Journal Article
 
Pre-Treatment Cytogenetics Predict Complete Remission and Long-Term Outcome in Patients (Pts) ≥60 Years with Acute Myeloid Leukemia (AML): Results from Cancer and Leukemia Group B (CALGB) 8461
Farag, Sherif SArcher, Kellie JMrózek, KrzysztofVardiman, James WCarroll, Andrew JPettenati, Mark JPowell, Bayard LMoore, Joseph OKolitz, Jonathan EBaer, Maria RBigner, Sandra HKoduru, Prasad RStamberg, JudithMayer, Robert JStone, Richard MSchiffer, Charles ALarson, Richard A and Bloomfield, Clara D
Blood, vol. 104, (no. 11), pp. 568, 2004-11-16. | Journal Article
 
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag, Sherif SRuppert, Amy SMrózek, KrzysztofCarroll, Andrew JPettenati, Mark JLe Beau, Michelle MPeterson, BercedisPowell, Bayard LOzer, HowardSilver, Richard TLarson, Richard A and Bloomfield, Clara D
International Journal of Oncology, vol. 25, (no. 1), pp. 143-51, 2004/Jul. | Journal Article
 
Single Institution Experience with Two High-Dose Chemotherapy (HDC) Conditioning Regimens Prior to Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM)
Benson, Don MElder, Patrick JLin, ThomasBlum, WilliamPenza, SamAvalos, BelindaByrd, John CCopelan, Edward and Farag, Sherif S
Blood, vol. 104, (no. 11), pp. 5214, 2004-11-16. | Journal Article
 
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation
Copelan, Edward AHoshaw-Woodard, S.Elder, P.Penza, Sam LFarag, Sherif SMarcucci, GuidoLin, T.Ezzone, S.Scholl, M. DBechtel, T.Lemeshow, Stanley and Avalos Copelan, Belinda
Bone Marrow Transplantation, vol. 34, (no. 1), pp. 85-87, Jul 2004. | Journal Article
2003
Biology and clinical impact of human natural killer cells.
Farag, Sherif SVanDeusen, Jeffrey BFehniger, Todd A and Caligiuri, Michael A
International Journal of Hematology, vol. 78, (no. 1), pp. 7-17, 2003/Jul. | Journal Article
 
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
Bruner, Rebecca JBruner, Rebecca JFarag, Sherif S and Farag, Sherif S
Seminars in Oncology, vol. 30, (no. 4), pp. 519, August 2003. | Journal Article
 
New directions in natural killer cell-based immunotherapy of human cancer.
Farag, Sherif SFehniger, Todd ABecknell, BrianBlaser, Bradley W and Caligiuri, Michael A
Expert Opinion on Biological Therapy, vol. 3, (no. 2), pp. 237-50, 2003/Apr. | Journal Article
 
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk disease.
Farag, Sherif SElder, P JMarcucci, GuidoPenza, Sam LMrozek, EMolina, ALin, TAvalos, B R and Copelan, E
Bone marrow transplantation, vol. 31, (no. 2), pp. 87-93, 2003/Jan. | Journal Article